多块判别分析整合18F-FDG-PET/CT影像组学预测早期非小细胞肺癌SBRT治疗中的循环肿瘤细胞
本研究纳入56例接受SBRT的I期NSCLC患者,于SBRT前及SBRT后(中位5个月)行18F-FDG-PET/CT,提取PET/CT影像组学特征,采用DIABLO多块整合判别分析预测CTC水平。单块sPLS-DA模型AUC均未超过0.7。
要点
- 单块sPLS-DA模型交叉验证AUC均未超过0.7,多块整合优于单块拼接。
核心结论
- 18F-FDG-PET/CT影像组学多块整合判别分析有潜力预测SBRT前和SBRT后CTC。
- 影像组学与CTC分析可能互补,共同帮助指导早期NSCLC患者后续管理。
研究设计与样本
- 纳入56例接受SBRT的I期NSCLC患者,SBRT前及SBRT后(中位5个月,范围3-10个月)行18F-FDG-PET/CT。
- SBRT前及SBRT后3个月内用端粒酶法检测CTC,以5和1.3 CTCs/mL二分类。
- 从大体肿瘤体积提取SBRT前、SBRT后及delta PET/CT影像组学特征,构建7个特征块(含12个临床参数)。
- 采用DIABLO(块稀疏偏最小二乘判别分析)进行多块数据整合,以成对组合法筛选最优输入块。
- 采用20×5折交叉验证的合并AUC评估DIABLO性能,并与拼接式sPLS-DA比较,交叉验证预测评分用Wilcoxon秩和检验比较。
主要发现
- 所有单块sPLS-DA模型的交叉验证AUC均未超过0.7。
关键数值与推荐
- CTC二分类阈值:5和1.3 CTCs/mL。
- 单块sPLS-DA模型交叉验证AUC均未超过0.7。
临床怎么用
- 对接受SBRT的I期NSCLC患者,可考虑用SBRT前PET影像组学联合临床特征预测SBRT前CTC水平。
- 可用SBRT后CT联合delta CT影像组学预测SBRT后CTC水平,影像组学与CTC分析可能互补指导后续管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The main objective of the present study was to integrate 18F-FDG-PET/CT radiomics with multiblock discriminant analysis for predicting circulating tumor cells (CTCs) in early-stage non-small cell lung cancer (ES-NSCLC) treated with stereotactic body radiation therapy (SBRT). METHODS: Fifty-six patients with stage I NSCLC treated with SBRT underwent 18F-FDG-PET/CT imaging pre-SBRT and post-SBRT (median, 5 months; range, 3-10 months). CTCs were assessed via a telomerase-based assay before and within 3 months after SBRT and dichotomized at 5 and 1.3 CTCs/mL. Pre-SBRT, post-SBRT, and delta PET/CT radiomics features (n = 1548 × 3/1562 × 3) were extracted from gross tumor volume. Seven feature blocks were constructed including clinical parameters (n = 12). Multiblock data integration was performed using block sparse partial least squares-discriminant analysis (sPLS-DA) referred to as Data Integration Analysis for Biomarker Discovery Using Latent Components (DIABLO) for identifying key signatures by maximizing common information between different feature blocks while discriminating CTC levels. Optimal input blocks were identified using a pairwise combination method. DIABLO performance for predicting pre-SBRT and post-SBRT CTCs was evaluated using combined AUC (area under the curve, averaged across different blocks) analysis with 20 × 5-fold cross-validation (CV) and compared with that of concatenation-based sPLS-DA that consisted of combining all features into 1 block. CV prediction scores between 1 class versus the other were compared using the Wilcoxon rank sum test. RESULTS: For predicting pre-SBRT CTCs, DIABLO achieved the best performance with combined pre-SBRT PET radiomics and clinical feature blocks, showing CV AUC of 0.875 (P = .009). For predicting post-SBRT CTCs, DIABLO achieved the best performance with combined post-SBRT CT and delta CT radiomics feature blocks, showing CV AUCs of 0.883 (P = .001). In contrast, all single-block sPLS-DA models could not attain CV AUCs higher than 0.7. CONCLUSIONS: Multiblock integration with discriminant analysis of 18F-FDG-PET/CT radiomics has the potential for predicting pre-SBRT and post-SBRT CTCs. Radiomics and CTC analysis may complement and together help guide the subsequent management of patients with ES-NSCLC.
引用
- Lee SH, Kao GD, Feigenberg SJ, et al. Multiblock Discriminant Analysis of Integrative 18F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021. PMID: 33662459. doi:10.1016/j.ijrobp.2021.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。